USE OF FAECAL CALPROTECTIN AS A PROGNOSTIC MARKER OF RESPONSE TO TREATMENT WITH FILGOTINIB: POST HOC ANALYSIS FROM THE SELECTION STUDY
Edouard Louis 1
Brian G. Feagan 2
Tadakazu Hisamatsu 3
Virginia Taliadouros 4
Rob Jongen 5
Carole Van der Donckt 5
Laurent Peyrin-Biroulet 6
1 CHU Liège University Hospital, Liège, Belgium
2 Alimentiv, London, Canada
3 Kyorin University School of Medicine, Tokyo, Japan
4 Galapagos NV, Leiden, Netherlands
5 Galapagos NV, Mechelen, Belgium
6 University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France
Session
IBD (Posters)
Conference
UEG Week Vienna 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]